Directa Plus (GB:DCTA) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Directa Plus, a key player in graphene nanoplatelet-based products, is launching a fundraising initiative aimed at generating between £6.8 million and £6.9 million to capitalize on significant growth opportunities. The fundraising includes a conditional placing and subscription, which will see the issue of over 38 million new shares, with Nant Capital LLC, the company’s largest shareholder, expressing substantial interest. The success of this fundraising, which is subject to shareholder approval, could mark a new phase of accelerated growth for the company.
For further insights into GB:DCTA stock, check out TipRanks’ Stock Analysis page.
